// App-Quantinova.ai

: Real World Analysis of the Incidence and Impact of Hypertension and Cardiac Toxicity Associated with Carfilzomib for Patients with Multiple Myeloma

Researchers

Presenter

  • Selina J Chavda

Principal Investigators

  • Rachael Pocock

  • Simon Cheesman

  • Emma Dowling

  • Puneet Verma

  • Malcolm Walker

  • Charalampia Kyriakou

  • Ashutosh D. Wechalekar

  • Neil K Rabin

  • Kwee Yong

  • Rakesh Popat

Medical Centers

  • Bart's Cancer Institute, London, United Kingdom

  • Haematology, University College London Hospitals NHS Foundation Trust (UCLH), London, United Kingdom

  • Department of Haematology, HCA Healthcare UK at University College London Hospitals, London, United Kingdom

  • Department of Cardiology, Hatter Cardiovascular Institute, University College London Hospitals NHS Foundation Trusts, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Cardiotoxicity

  • Multiple Myeloma

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • carfilzomib Intravenous

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved